Table 2 Prevalence of cardiometabolic comorbidities on initial evaluation
From: Cardiometabolic healthcare for men with prostate cancer: an MD Anderson Cancer Center experience
Cardiometabolic comorbidity | Prevalence in cohort (n = 55) |
|---|---|
Coronary artery disease | |
Yes | 8 (14.6%) |
No | 47 (85.4%) |
Prior cerebrovascular accident | |
Yes | 1 (1.8%) |
No | 54 (98.2%) |
Hyperlipidemia | |
Yes | 38 (69.1%) |
No | 17 (30.9%) |
Hypertension | |
Yes | 38 (69.1%) |
No | 17 (30.9%) |
Tobacco abuse | |
Current smoker | 1 (1.8%) |
Former smoker | 18 (32.7%) |
Non-smoker | 36 (65.5%) |
Diabetes mellitus | |
Yes | 14 (25.5%) |
No | 41 (74.5%) |
Comorbidity overlap | |
1 comorbidity | 9 (16.4%) |
2 comorbidities | 17 (30.9%) |
3 comorbidities | 11 (20%) |
≥ 4 comorbidities | 14 (25.5%) |